Meghmani Organics Limited (IN:MOL)
:MOL
Top Page
Meghmani Organics Limited
(MOL)
Select Model
Select Model
Rating:46Neutral
Price Target:
₹49.00
▼(-24.37% Downside)
Action:ReiteratedDate:03/19/26
Overall score is weighed down primarily by weak financial performance (losses, high leverage, and negative free cash flow). Technicals are also bearish with a strong downtrend, despite oversold readings. Valuation provides limited support due to negative earnings and no dividend yield data.
Positive Factors
Product Diversification
Meghmani's dual focus on pigments and agrochemicals gives it exposure to multiple end markets (paints, plastics, inks, textiles, agriculture). This structural diversification reduces reliance on any single demand cycle and supports more stable revenue opportunities over months to years.
Negative Factors
High Leverage
A high debt-to-equity ratio raises interest and refinancing burdens and narrows financial flexibility. With elevated leverage, the company is more vulnerable to demand or margin shocks and has less capacity to invest or absorb shocks without raising costly external funding.
Read all positive and negative factors
Positive Factors
Negative Factors
Product Diversification
Meghmani's dual focus on pigments and agrochemicals gives it exposure to multiple end markets (paints, plastics, inks, textiles, agriculture). This structural diversification reduces reliance on any single demand cycle and supports more stable revenue opportunities over months to years.
Read all positive factors
Meghmani Organics Limited (MOL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹12.63B
Dividend YieldN/A
Average Volume (3M)53.48K
Price to Earnings (P/E)―
Beta (1Y)1.36
Revenue GrowthN/A
EPS GrowthN/A
CountryIN
Employees1,720
SectorBasic Materials
Sector Strength58
IndustryAgricultural Inputs
Share Statistics
EPS (TTM)-0.14
Shares Outstanding254,314,210
10 Day Avg. Volume52,595
30 Day Avg. Volume53,476
Financial Highlights & Ratios
PEG Ratio1.75
Price to Book (P/B)1.10
Price to Sales (P/S)0.78
P/FCF Ratio-73.36
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)4.4
Revenue Forecast (FY)₹30.55B
Meghmani Organics Limited Business Overview & Revenue Model
Company Description
Meghmani Organics Limited manufactures and sells pigments and agrochemicals in India and internationally. It offers green and blue pigments, which are used in printing inks, paints and coatings, and plastics. The company also provides agrochemical...
How the Company Makes Money
MOL primarily makes money by manufacturing chemicals and selling them to business customers and distributors in domestic and export markets. Its core revenue streams are (1) pigments: sales of phthalocyanine pigments and related pigment products s...
Meghmani Organics Limited Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
55
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 23.13B | 21.24B | 15.48B | 25.28B | 24.73B | 16.12B |
| Gross Profit | 8.69B | 8.60B | 5.21B | 4.79B | 10.01B | 6.93B |
| EBITDA | 2.72B | 1.87B | 119.50M | 4.10B | 4.81B | 3.11B |
| Net Income | 396.62M | -106.01M | -1.06B | 2.38B | 3.04B | 1.86B |
Balance Sheet | ||||||
| Total Assets | 32.85B | 30.85B | 30.40B | 31.98B | 27.98B | 19.74B |
| Cash, Cash Equivalents and Short-Term Investments | 412.99M | 227.24M | 330.74M | 1.52B | 117.22M | 1.23B |
| Total Debt | 8.41B | 8.29B | 8.37B | 8.24B | 4.99B | 2.68B |
| Total Liabilities | 17.45B | 15.70B | 15.12B | 15.29B | 13.31B | 8.01B |
| Stockholders Equity | 15.40B | 15.15B | 15.28B | 16.69B | 14.66B | 11.73B |
Cash Flow | ||||||
| Free Cash Flow | 422.76M | -226.88M | -165.29M | -2.61B | -1.79B | 1.24B |
| Operating Cash Flow | 668.34M | 662.22M | 2.50B | 2.04B | 648.32M | 3.33B |
| Investing Cash Flow | -211.79M | 309.70M | -1.78B | -4.18B | -1.33B | -3.07B |
| Financing Cash Flow | -373.49M | -913.88M | -854.77M | 2.34B | 577.19M | -142.40M |
Meghmani Organics Limited Technical Analysis
Neutral
64.79
Price Trends
49.49
Positive
56.94
Negative
72.13
Negative
Market Momentum
-0.30
Negative
57.41
Neutral
90.73
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MOL, the sentiment is Neutral. The current price of 64.79 is above the 20-day moving average (MA) of 43.87, above the 50-day MA of 49.49, and below the 200-day MA of 72.13, indicating a neutral trend. The MACD of -0.30 indicates Negative momentum. The RSI at 57.41 is Neutral, neither overbought nor oversold. The STOCH value of 90.73 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IN:MOL.
Meghmani Organics Limited Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ₹27.14B | 23.71 | ― | 0.65% | -10.12% | -22.38% | |
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
60 Neutral | ₹24.11B | 29.38 | ― | 0.97% | 5.74% | 16.06% | |
58 Neutral | ₹9.40B | 36.69 | ― | 2.08% | 4.65% | -127.24% | |
57 Neutral | ₹12.67B | 85.72 | ― | 0.16% | 0.95% | 488.81% | |
53 Neutral | ₹28.18B | 51.39 | ― | 0.07% | 16.88% | 0.69% | |
46 Neutral | ₹12.63B | -115.81 | ― | ― | ― | ― |
* Basic Materials Sector Average
IN:MOL
Meghmani Organics Limited
49.68
-17.48
-26.03%
IN:DCW
DCW Ltd.
44.57
-30.78
-40.85%
IN:FCL
Fineotex Chemical Limited
23.41
0.73
3.22%
IN:IOLCP
IOL Chemicals & Pharmaceuticals Ltd.
82.13
21.23
34.85%
IN:TATVA
Tatva Chintan Pharma Chem Limited
1,204.80
510.09
73.42%
IN:TNPL
Tamil Nadu Newsprint & Papers Ltd.
135.75
11.14
8.94%
Meghmani Organics Limited Corporate Events
Meghmani Organics Alerts Investors on Transfer of Unclaimed Dividends and Shares to IEPF
Feb 19, 2026
Meghmani Organics Limited has notified the stock exchanges that it has published newspaper advertisements on 19 February 2026 in the English and Gujarati editions of Financial Express. The notices advise shareholders with unclaimed dividends for s...
Meghmani Organics Releases Q3 FY26 Investor Presentation on Unaudited Results
Jan 31, 2026
Meghmani Organics Limited has released an investor presentation detailing its unaudited financial results for the third quarter and nine months ended 31 December 2025, in line with disclosure requirements under SEBI’s listing regulations. Th...
Meghmani Organics Q3 Profit Slips on Export Weakness, Nine-Month Earnings Surge
Jan 31, 2026
Meghmani Organics reported a 13% year-on-year decline in standalone Q3 FY26 revenue to ₹484.9 crore, with EBITDA down 15% and net profit falling 26%, as lower export demand and reduced capacity utilisation in both crop protection and pigment...
Meghmani Organics Schedules Q3 FY26 Earnings Call for 2 February
Jan 28, 2026
Meghmani Organics Limited has announced that it will hold its earnings call for the third quarter of fiscal year 2025-26 on Monday, 2 February 2026 at 3:00 p.m. IST. Senior management, including the chairman and managing director, chief financial ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.